Medexus Pharmaceuticals Inc. MEDXF
3.61 USD +0.05 (+1.55%)
At closeNov 4, 2026, 4:00 PM EST
3.48 Day range 3.50
1.80 52-week range 3.96
- YTD
- +71.09%
- 1 year
- +89.01%
News
newsfilecorp.com Medexus Schedules Second Fiscal Quarter 2027 Conference Call Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 3, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday,…
newsfilecorp.com Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 24, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus…
seekingalpha.com Medexus Pharmaceuticals Inc. (MDP:CA) Shareholder/Analyst Call Prepared Remarks Transcript Medexus Pharmaceuticals Inc. (MDP:CA) Shareholder/Analyst Call Prepared Remarks Transcript
newsfilecorp.com Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date Fiscal Q1 2027 includes product-level net revenue from GRAFAPEX™ (treosulfan) for Injection of $4.9 million relative to $3.2 million of GRAFAPEX personnel and infrastructure investments Commercial…
newsfilecorp.com Medexus Schedules First Fiscal Quarter 2027 Conference Call Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - July 30, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Tuesday, August…
newsfilecorp.com Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection Management to host conference call at 8:00 AM Eastern time on Friday, June 26, 2026 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2026) - Medexus Pharmaceuticals (TSX: MDP)…
newsfilecorp.com Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June…
newsfilecorp.com Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel) Securing Canadian rights to a proprietary advanced clinical-stage product candidate developed in Canada adds to…
newsfilecorp.com Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 15, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today provided an operational business update on the ongoing…
seekingalpha.com Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call Transcript Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call Transcript
newsfilecorp.com Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection Management to host conference call at 8:00 AM Eastern time on Thursday, February 12, 2026 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 11, 2026) - Medexus Pharmaceuticals (TSX:…
newsfilecorp.com Medexus Schedules Third Fiscal Quarter 2026 Conference Call Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 3, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday,…
newsfilecorp.com Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 20, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the Toronto Stock Exchange has accepted…
newsfilecorp.com Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 17, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today entered into a new senior secured credit agreement with National…
seekingalpha.com Medexus Pharmaceuticals Inc. (MDP:CA) Q2 2026 Earnings Call Transcript Medexus Pharmaceuticals Inc. ( MDP:CA ) Q2 2026 Earnings Call November 13, 2025 8:00 AM EST Company Participants Kenneth d'Entremont - CEO & Director Brendon Bushman - Chief Financial Officer…
newsfilecorp.com Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection Management to host conference call at 8:00 AM Eastern time on Thursday, November 13, 2025 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 12, 2025) - Medexus Pharmaceuticals (TSX:…
newsfilecorp.com Medexus Schedules Second Fiscal Quarter 2026 Conference Call Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 4, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday,…
newsfilecorp.com Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 25, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus…
seekingalpha.com Medexus Pharmaceuticals Inc. (MDP:CA) Shareholder/Analyst Call Prepared Remarks Transcript Medexus Pharmaceuticals Inc. (TSX:MDP:CA ) Shareholder/Analyst Call September 25, 2025 10:00 AM EDT Company Participants Michael Mueller Ian Wildgoose Brown - General Counsel & Corporate Secretary…
seekingalpha.com Medexus Pharmaceuticals Inc. (MEDXF) Q1 2026 Earnings Call Transcript Medexus Pharmaceuticals Inc. (OTCQX:MEDXF) Q1 2026 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Brendon Buschman - Chief Financial Officer Kenneth d'Entremont - CEO &…